FDA recall D-0250-2026

Product

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.

Reason for recall

Presence of particulate matter - Glass like particles.

Distribution

U.S Nationwide

Key facts

Status

Ongoing

Initiation date

2025-12-18

Report date

2026-01-14

Voluntary/Mandated

Voluntary: Firm initiated

Location

Ledgewood, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0250-2026